Corticosteroids Use and Incidence of Severe Infections in People Living with HIV Compared to a Matched Population

Background: People living with HIV (PLWH) have been shown to have an increased risk of autoimmune diseases. Corticosteroids are the cornerstone of autoimmune diseases treatment, but their use is associated with an increased risk of infections. It is unclear how HIV status affects the risk of infecti...

Full description

Bibliographic Details
Main Authors: Joseph Junior Damba MD, MSc, Mikhael Laskine MD, MSc, Marc Messier Peet MSc, Yulan Jin MA, Liliya Sinyavskaya MD, Madeleine Durand MD, MSc
Format: Article
Language:English
Published: SAGE Publishing 2022-06-01
Series:Journal of the International Association of Providers of AIDS Care
Online Access:https://doi.org/10.1177/23259582221107196
_version_ 1811250065708154880
author Joseph Junior Damba MD, MSc
Mikhael Laskine MD, MSc
Marc Messier Peet MSc
Yulan Jin MA
Liliya Sinyavskaya MD
Madeleine Durand MD, MSc
author_facet Joseph Junior Damba MD, MSc
Mikhael Laskine MD, MSc
Marc Messier Peet MSc
Yulan Jin MA
Liliya Sinyavskaya MD
Madeleine Durand MD, MSc
author_sort Joseph Junior Damba MD, MSc
collection DOAJ
description Background: People living with HIV (PLWH) have been shown to have an increased risk of autoimmune diseases. Corticosteroids are the cornerstone of autoimmune diseases treatment, but their use is associated with an increased risk of infections. It is unclear how HIV status affects the risk of infection associated with corticosteroids use. Methods: We conducted a retrospective cohort study from 1991 to 2011, using a medico-administrative database from Quebec. Medical billing codes were used to identify PLWH, and we matched them on age, sex, and index date with up to 4 HIV-negative controls. The exposure of interest was the use of corticosteroids, defined as a systemic corticosteroid dispensation lasting at least 20 days. The outcome of interest was hospitalization for severe infection. Crude and adjusted incidence rates ratios of infection were obtained using a random effect Poisson model, and results were stratified by HIV status. Results: In total, 4798 PLWH were matched to 17 644 HIV-negative controls, among which 1083 (22.6%) PLWH and 1854 (10.5%) HIV-negative controls received at least one course of corticosteroid. The mean duration of corticosteroids use was 4 ± 4.4 months in PLWH and 1.6 ± 5.5 months in HIV-negative controls. The incidence rate ratio (IRR) for infections associated with corticosteroids use was 2.49[1.71–3.60] in PLWH and 1.32[0.71–2.47] in HIV-negative controls (P value for interaction 0.18). The most frequent infections were pulmonary infections (50.4%), followed by urinary tract infections (26%) and opportunistic infections (10.5%). Conclusion: Although our interaction term did not reach significance, the increased risk of infection associated with corticosteroids use was more pronounced in PLWH. However, further research with contemporary data is warranted to confirm if the risk associated with corticosteroids use remains high in PLWH with well-controlled HIV infection.
first_indexed 2024-04-12T15:57:30Z
format Article
id doaj.art-c359ffbafe1e42989bee9893921407be
institution Directory Open Access Journal
issn 2325-9582
language English
last_indexed 2024-04-12T15:57:30Z
publishDate 2022-06-01
publisher SAGE Publishing
record_format Article
series Journal of the International Association of Providers of AIDS Care
spelling doaj.art-c359ffbafe1e42989bee9893921407be2022-12-22T03:26:18ZengSAGE PublishingJournal of the International Association of Providers of AIDS Care2325-95822022-06-012110.1177/23259582221107196Corticosteroids Use and Incidence of Severe Infections in People Living with HIV Compared to a Matched PopulationJoseph Junior Damba MD, MSc0Mikhael Laskine MD, MSc1Marc Messier Peet MSc2Yulan Jin MA3Liliya Sinyavskaya MD4Madeleine Durand MD, MSc5 Centre de recherche du centre hospitalier universitaire de Montréal (CRCHUM), Montréal, Québec, Canada Internal Medicine Service, Centre hospitalier universitaire de Montréal (CHUM), Montréal, Québec, Canada Centre de recherche du centre hospitalier universitaire de Montréal (CRCHUM), Montréal, Québec, Canada Centre de recherche du centre hospitalier universitaire de Montréal (CRCHUM), Montréal, Québec, Canada Centre de recherche du centre hospitalier universitaire de Montréal (CRCHUM), Montréal, Québec, Canada Internal Medicine Service, Centre hospitalier universitaire de Montréal (CHUM), Montréal, Québec, CanadaBackground: People living with HIV (PLWH) have been shown to have an increased risk of autoimmune diseases. Corticosteroids are the cornerstone of autoimmune diseases treatment, but their use is associated with an increased risk of infections. It is unclear how HIV status affects the risk of infection associated with corticosteroids use. Methods: We conducted a retrospective cohort study from 1991 to 2011, using a medico-administrative database from Quebec. Medical billing codes were used to identify PLWH, and we matched them on age, sex, and index date with up to 4 HIV-negative controls. The exposure of interest was the use of corticosteroids, defined as a systemic corticosteroid dispensation lasting at least 20 days. The outcome of interest was hospitalization for severe infection. Crude and adjusted incidence rates ratios of infection were obtained using a random effect Poisson model, and results were stratified by HIV status. Results: In total, 4798 PLWH were matched to 17 644 HIV-negative controls, among which 1083 (22.6%) PLWH and 1854 (10.5%) HIV-negative controls received at least one course of corticosteroid. The mean duration of corticosteroids use was 4 ± 4.4 months in PLWH and 1.6 ± 5.5 months in HIV-negative controls. The incidence rate ratio (IRR) for infections associated with corticosteroids use was 2.49[1.71–3.60] in PLWH and 1.32[0.71–2.47] in HIV-negative controls (P value for interaction 0.18). The most frequent infections were pulmonary infections (50.4%), followed by urinary tract infections (26%) and opportunistic infections (10.5%). Conclusion: Although our interaction term did not reach significance, the increased risk of infection associated with corticosteroids use was more pronounced in PLWH. However, further research with contemporary data is warranted to confirm if the risk associated with corticosteroids use remains high in PLWH with well-controlled HIV infection.https://doi.org/10.1177/23259582221107196
spellingShingle Joseph Junior Damba MD, MSc
Mikhael Laskine MD, MSc
Marc Messier Peet MSc
Yulan Jin MA
Liliya Sinyavskaya MD
Madeleine Durand MD, MSc
Corticosteroids Use and Incidence of Severe Infections in People Living with HIV Compared to a Matched Population
Journal of the International Association of Providers of AIDS Care
title Corticosteroids Use and Incidence of Severe Infections in People Living with HIV Compared to a Matched Population
title_full Corticosteroids Use and Incidence of Severe Infections in People Living with HIV Compared to a Matched Population
title_fullStr Corticosteroids Use and Incidence of Severe Infections in People Living with HIV Compared to a Matched Population
title_full_unstemmed Corticosteroids Use and Incidence of Severe Infections in People Living with HIV Compared to a Matched Population
title_short Corticosteroids Use and Incidence of Severe Infections in People Living with HIV Compared to a Matched Population
title_sort corticosteroids use and incidence of severe infections in people living with hiv compared to a matched population
url https://doi.org/10.1177/23259582221107196
work_keys_str_mv AT josephjuniordambamdmsc corticosteroidsuseandincidenceofsevereinfectionsinpeoplelivingwithhivcomparedtoamatchedpopulation
AT mikhaellaskinemdmsc corticosteroidsuseandincidenceofsevereinfectionsinpeoplelivingwithhivcomparedtoamatchedpopulation
AT marcmessierpeetmsc corticosteroidsuseandincidenceofsevereinfectionsinpeoplelivingwithhivcomparedtoamatchedpopulation
AT yulanjinma corticosteroidsuseandincidenceofsevereinfectionsinpeoplelivingwithhivcomparedtoamatchedpopulation
AT liliyasinyavskayamd corticosteroidsuseandincidenceofsevereinfectionsinpeoplelivingwithhivcomparedtoamatchedpopulation
AT madeleinedurandmdmsc corticosteroidsuseandincidenceofsevereinfectionsinpeoplelivingwithhivcomparedtoamatchedpopulation